ProShares Ultra Nasdaq Biotechnology (BIB)
- Expense ratio0.95%
- Net assets$94.8M
- Dividend yield0.19%
- 1-year return+73.77%
- Holdings246
BIB ETF price chart
BIB quote & trading statistics
BIB performance
Annual returns & drawdowns →- YTD+40.37%
- 1 year+73.77%
- 3 years+39.82%/yr
- 5 years+5.49%/yr
- 10 years+10.95%/yr
- 1Y volatility
- 36.71%
- 3Y volatility
- 36.77%
- 3Y Sharpe ratio
- 0.92
Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.
BIB top 10 holdings
All holdings →| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | IQMM | Proshares Genius Money Market ETF | 18.43% |
| 2 | GILD | Gilead Sciences Inc | 5.17% |
| 3 | VRTX | Vertex Pharmaceuticals Inc | 5.05% |
| 4 | AMGN | Amgen Inc | 4.91% |
| 5 | MRNA | Moderna Inc | 3.35% |
| 6 | REGN | Regeneron Pharmaceuticals Inc | 3.25% |
| 7 | RVMD | Revolution Medicines Inc | 1.64% |
| 8 | ILMN | Illumina Inc | 1.62% |
| 9 | BIIB | Biogen Inc | 1.55% |
| 10 | ALNY | Alnylam Pharmaceuticals Inc | 1.22% |
The top 10 holdings make up 46.2% of the fund (246 holdings in total). As of October 25, 2026.
About ProShares Ultra Nasdaq Biotechnology
The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
BIB ETF FAQ
What is the BIB expense ratio?
ProShares Ultra Nasdaq Biotechnology has a net expense ratio of 0.95%, or $95.00 a year for every $10,000 invested.
How much money is in BIB?
ProShares Ultra Nasdaq Biotechnology has about $94.8M in net assets.
What are the top holdings of BIB?
The largest positions in BIB are Proshares Genius Money Market ETF (18.43%), Gilead Sciences Inc (5.17%), Vertex Pharmaceuticals Inc (5.05%). The fund holds 246 securities in total.
How has BIB performed?
BIB returned +73.77% over the past year and +5.49% a year over the past five years, including reinvested distributions.
Does BIB pay dividends?
BIB has a dividend yield of 0.19% and pays distributions quarterly.
When was BIB launched?
ProShares Ultra Nasdaq Biotechnology began trading on April 6, 2010.
ETFs similar to BIB
Funds that track the same index or whose top-10 holdings overlap most with BIB's. Overlap: shared top-10 weight as a share of the larger top-10 total of the two funds.
| Symbol | Fund | Overlap | Expense ratio | Net assets | 1-year return |
|---|---|---|---|---|---|
| BIB | ProShares Ultra Nasdaq Biotechnology | — | 0.95% | $94.8M | +73.77% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 59% | 0.18% | $113.9M | +38.28% |
| IBB | iShares Biotechnology ETF | 52% | 0.46% | $10.73B | +33.96% |
| BIS | ProShares UltraShort Nasdaq Biotechnology | 51% | 0.96% | $1.9M | -48.12% |